Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial—PEARL
Martin, M., Zielinski, C., Ruiz-Borrego, M., Carrasco, E., Turner, N., Ciruelos, E.M., Muñoz, M., Bermejo, B., Margeli, M., Anton, A., Kahan, Z., Csöszi, T., Casas, M.I., Murillo, L., Morales, S., Alba, E., Gal-Yam, E., Guerrero-Zotano, A., Calvo, L., de la Haba-Rodriguez, J., Ramos, M., Alvarez, I., Garcia-Palomo, A., Huang Bartlett, C., Koehler, M., Caballero, R., Corsaro, M., Huang, X., Garcia-Sáenz, J.A., Chacón, J.I., Swift, C., Thallinger, C., Gil-Gil, M.
Published in Annals of oncology (01.04.2021)
Published in Annals of oncology (01.04.2021)
Get full text
Journal Article
Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent/metastatic breast cancer
Vrdoljak, E., Marschner, N., Zielinski, C., Gligorov, J., Cortes, J., Puglisi, F., Aapro, M., Fallowfield, L., Fontana, A., Inbar, M., Kahan, Z., Welt, A., Lévy, C., Brain, E., Pivot, X., Putzu, C., González Martín, A., de Ducla, S., Easton, V., von Minckwitz, G.
Published in Annals of oncology (01.11.2016)
Published in Annals of oncology (01.11.2016)
Get full text
Journal Article
Safe switch of treatment from the reference product to RGB-02, a proposed biosimilar pegfilgrastim: Analysis of the results of three clinical trials
Illes, A., Perjesi, L., Horvat-Karajz, K., Jeszenoi, N., Aradi, I., Singh, N.K., Mair, S.J., Kahan, Z.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses
Brodowicz, T, Lang, I, Kahan, Z, Greil, R, Beslija, S, Stemmer, S M, Kaufman, B, Petruzelka, L, Eniu, A, Anghel, R, Koynov, K, Vrbanec, D, Pienkowski, T, Melichar, B, Spanik, S, Ahlers, S, Messinger, D, Inbar, M J, Zielinski, C
Published in British journal of cancer (25.11.2014)
Published in British journal of cancer (25.11.2014)
Get full text
Journal Article
1800 Final results for overall survival (OS), the primary endpoint of the CECOG TURANDOT prospective randomised trial evaluating bevacizumab-paclitaxel (BEV-PAC) vs BEV-capecitabine (CAP) for HER2-negative locally recurrent/metastatic breast cancer (LR/mBC)
Zielinski, C.C, Lang, I, Inbar, M, Kahan, Z, Greil, R, Beslija, S, Stemmer, S.M, Zvirbule, Z, Steger, G.G, Melichar, B, Pienkowski, T, Sirbu, D, Petruzelka, L, Eniu, A, Nisenbaum, B, Dank, M, Anghel, R, Messinger, D, Brodowicz, T
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
Expression of growth hormone-releasing hormone (GHRH) messenger ribonucleic acid and the presence of biologically active GHRH in human breast, endometrial, and ovarian cancers
KAHAN, Z, ARENCIBIA, J. M, CSERNUS, V. J, GROOT, K, KINEMAN, R. D, ROBINSON, W. R, SCHALLY, A. V
Published in The journal of clinical endocrinology and metabolism (01.02.1999)
Published in The journal of clinical endocrinology and metabolism (01.02.1999)
Get full text
Journal Article
Acute oesophageal toxicity related to paclitaxel-based concurrent chemoradiotherapy for non-small cell lung cancer
Maráz, Anikó, Furák, József, Varga, Zoltán, Fodor, Emese, Együd, Zsófia, Borzási, Emoke, Kahán, Zsuzsanna, Pálföldi, Regina, Tiszlavicz, László, Hideghéty, Katalin
Published in Anticancer research (01.04.2013)
Get full text
Published in Anticancer research (01.04.2013)
Journal Article
Synthesis and Biological Evaluation of Cytotoxic Analogs of Somatostatin Containing Doxorubicin or Its Intensely Potent Derivative, 2-pyrrolinodoxorubicin
Nagy, Attila, Schally, Andrew V., Halmos, Gabor, Armatis, Patricia, Cai, Ren-Zhi, Csernus, Valer, Kovacs, Magdolna, Koppan, Miklos, Szepeshazi, Karoly, Kahan, Zsuzsanna
Published in Proceedings of the National Academy of Sciences - PNAS (17.02.1998)
Published in Proceedings of the National Academy of Sciences - PNAS (17.02.1998)
Get full text
Journal Article
Antagonists of growth hormone-releasing hormone arrest the growth of MDA-MB-468 estrogen-independent human breast cancers in nude mice
Kahán, Z, Varga, J L, Schally, A V, Rékási, Z, Armatis, P, Chatzistamou, L, Czömpöly, T, Halmos, G
Published in Breast cancer research and treatment (01.03.2000)
Published in Breast cancer research and treatment (01.03.2000)
Get full text
Journal Article
Safety results from a phase III study (TURANDOT trial by CECOG) of first-line bevacizumab in combination with capecitabine or paclitaxel for HER-2-negative locally recurrent or metastatic breast cancer
Lang, I, Inbar, M.J, Kahán, Z, Greil, R, Beslija, S, Stemmer, S.M, Kaufman, B, Zvirbule, Z, Steger, G.G, Messinger, D, Brodowicz, T, Zielinski, C
Published in European journal of cancer (1990) (01.11.2012)
Published in European journal of cancer (1990) (01.11.2012)
Get full text
Journal Article
Ocular abnormality as the first sign of metastatic breast cancer: the presentation of two cases
Kahán, Z., Szabó, Á., Cserháti, A.
Published in Memo - Magazine of European medical oncology (01.09.2008)
Published in Memo - Magazine of European medical oncology (01.09.2008)
Get full text
Journal Article
Inhibition of growth of MDA‐MB‐468 estrogen‐independent human breast carcinoma by bombesin/gastrin‐releasing peptide antagonists RC‐3095 and RC‐3940‐II
Kahán, Zsuzsanna, Sun, Baodong, Schally, Andrew V., Arencibia, José M., Cai, Ren‐Zhi, Groot, Kate, Halmos, Gábor
Published in Cancer (15.03.2000)
Published in Cancer (15.03.2000)
Get full text
Journal Article
Efficacy and safety of RGB-02, a proposed biosimilar pegfilgrastim to prevent chemotherapy-induced neutropenia: Results of a randomized, double-blind, phase III clinical study vs. reference pegfilgrastim in patients with breast cancer receiving docetaxel/doxorubicin
Horvat-Karajz, K., Grecea, D., Smakal, M., Illes, A., Kahan, Z.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
1700PSafe switch of treatment from the reference product to RGB-02, a proposed biosimilar pegfilgrastim: Analysis of the results of three clinical trials
Illes, A, Perjesi, L, Horvat-Karajz, K, Jeszenoi, N, Aradi, I, Singh, N K, Mair, S J, Kahan, Z
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
229MO Overall survival (OS) of palbociclib (P) plus endocrine therapy (ET) versus capecitabine (CAP) in hormone-receptor+/HER2- metastatic breast cancer (MBC) that progressed on aromatase inhibitors (AIs): Final results of the PEARL study
Martin Jimenez, M., Zielinski, C., Ruiz-Borrego, M., Carrasco, E., Ciruelos, E.M., Muñoz, M., Bermejo, B., Margeli, M., Csoszi, T., Anton, A., Turner, N., Casas, M.I., Morales, S., Alba, E., Calvo, L., De La Haba, J., Ramos, M., Corsaro, M., Kahan, Z., Gil-Gil, M.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
143P Quality of life (QoL) with palbociclib (PAL) plus endocrine therapy (ET) versus (vs) capecitabine (CAP) in luminal metastatic breast cancer (MBC) patients (pts) in the PEARL study
Kahan, Z., Gil-Gil, M., Ruiz-Borrego, M., Carrasco, E.M., Ciruelos, E.M., Muñoz, M., Bermejo De Las Heras, B., Margeli Vila, M., Anton, A., Casas, M., Calvo, L., de la Haba, J., Ramos, M., Álvarez-López, I., Gal-Yam, E., Gautier, E., Corsaro, M., Rodrigálvarez, G., Zielinski, C., Martin Jimenez, M.
Published in Annals of oncology (01.05.2020)
Published in Annals of oncology (01.05.2020)
Get full text
Journal Article